These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 37922934)

  • 1. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups.
    Karschnia P; Smits M; Reifenberger G; Le Rhun E; Ellingson BM; Galldiks N; Kim MM; Huse JT; Schnell O; Harter PN; Mohme M; ; von Baumgarten L; Albert NL; Huang RY; Mehta MP; van den Bent M; Weller M; Vogelbaum MA; Chang SM; Berger MS; Tonn JC
    Lancet Oncol; 2023 Nov; 24(11):e438-e450. PubMed ID: 37922934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults.
    Wen PY; van den Bent M; Youssef G; Cloughesy TF; Ellingson BM; Weller M; Galanis E; Barboriak DP; de Groot J; Gilbert MR; Huang R; Lassman AB; Mehta M; Molinaro AM; Preusser M; Rahman R; Shankar LK; Stupp R; Villanueva-Meyer JE; Wick W; Macdonald DR; Reardon DA; Vogelbaum MA; Chang SM
    J Clin Oncol; 2023 Nov; 41(33):5187-5199. PubMed ID: 37774317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group.
    Karschnia P; Gerritsen JKW; Teske N; Cahill DP; Jakola AS; van den Bent M; Weller M; Schnell O; Vik-Mo EO; Thon N; Vincent AJPE; Kim MM; Reifenberger G; Chang SM; Hervey-Jumper SL; Berger MS; Tonn JC
    Lancet Oncol; 2024 Sep; 25(9):e404-e419. PubMed ID: 39214112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.
    Vogelbaum MA; Jost S; Aghi MK; Heimberger AB; Sampson JH; Wen PY; Macdonald DR; Van den Bent MJ; Chang SM
    Neurosurgery; 2012 Jan; 70(1):234-43; discussion 243-4. PubMed ID: 21593697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated Response Assessment in Neuro-Oncology (RANO) for Gliomas.
    Youssef G; Wen PY
    Curr Neurol Neurosci Rep; 2024 Feb; 24(2):17-25. PubMed ID: 38170429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma.
    Youssef G; Rahman R; Bay C; Wang W; Lim-Fat MJ; Arnaout O; Bi WL; Cagney DN; Chang YS; Cloughesy TF; DeSalvo M; Ellingson BM; Flood TF; Gerstner ER; Gonzalez Castro LN; Guenette JP; Kim AE; Lee EQ; McFaline-Figueroa JR; Potter CA; Reardon DA; Huang RY; Wen PY
    J Clin Oncol; 2023 Jun; 41(17):3160-3171. PubMed ID: 37027809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
    Albert NL; Galldiks N; Ellingson BM; van den Bent MJ; Chang SM; Cicone F; de Groot J; Koh ES; Law I; Le Rhun E; Mair MJ; Minniti G; Rudà R; Scott AM; Short SC; Smits M; Suchorska B; Tolboom N; Traub-Weidinger T; Tonn JC; Verger A; Weller M; Wen PY; Preusser M
    Lancet Oncol; 2024 Jan; 25(1):e29-e41. PubMed ID: 38181810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints.
    Huang RY; Wen PY
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):705-718. PubMed ID: 27742111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]Fluoroethyl-L-tyrosine PET in comparison to MRI.
    Galldiks N; Rapp M; Stoffels G; Fink GR; Shah NJ; Coenen HH; Sabel M; Langen KJ
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):22-33. PubMed ID: 23053325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect group.
    Karschnia P; Dono A; Young JS; Juenger ST; Teske N; Häni L; Sciortino T; Mau CY; Bruno F; Nunez L; Morshed RA; Haddad AF; Weller M; van den Bent M; Beck J; Hervey-Jumper S; Molinaro AM; Tandon N; Rudà R; Vogelbaum MA; Bello L; Schnell O; Grau SJ; Chang SM; Berger MS; Esquenazi Y; Tonn JC
    Neuro Oncol; 2023 Sep; 25(9):1672-1685. PubMed ID: 37253096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
    Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
    Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.
    Jaspan T; Morgan PS; Warmuth-Metz M; Sanchez Aliaga E; Warren D; Calmon R; Grill J; Hargrave D; Garcia J; Zahlmann G
    AJNR Am J Neuroradiol; 2016 Sep; 37(9):1581-7. PubMed ID: 27127006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FLAIR signal increase of the fluid within the resection cavity after glioma surgery: generally valid as early recurrence marker?
    Bette S; Gempt J; Huber T; Delbridge C; Meyer B; Zimmer C; Kirschke JS; Boeckh-Behrens T
    J Neurosurg; 2017 Aug; 127(2):417-425. PubMed ID: 27767397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice.
    Sanvito F; Castellano A; Cloughesy TF; Wen PY; Ellingson BM
    Curr Opin Oncol; 2024 Nov; 36(6):536-544. PubMed ID: 39011735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
    Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
    J Neurosurg; 2020 Feb; 132(2):518-529. PubMed ID: 30717057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Aminolevulinic Acid Hydrochloride (5-ALA)-Guided Surgical Resection of High-Grade Gliomas: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(9):1-92. PubMed ID: 32194883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
    Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
    Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based recommendations on categories for extent of resection in diffuse glioma.
    Karschnia P; Vogelbaum MA; van den Bent M; Cahill DP; Bello L; Narita Y; Berger MS; Weller M; Tonn JC
    Eur J Cancer; 2021 May; 149():23-33. PubMed ID: 33819718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-ALA-induced fluorescence behavior of reactive tissue changes following glioblastoma treatment with radiation and chemotherapy.
    Kamp MA; Felsberg J; Sadat H; Kuzibaev J; Steiger HJ; Rapp M; Reifenberger G; Dibué M; Sabel M
    Acta Neurochir (Wien); 2015 Feb; 157(2):207-13; discussion 213-4. PubMed ID: 25547719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of detecting malignant transformation of low-grade glioma using O-(2-[18F]fluoroethyl)-l-tyrosine positron emission tomography: a retrospective study.
    Bashir A; Brennum J; Broholm H; Law I
    J Neurosurg; 2018 Apr; 130(2):451-464. PubMed ID: 29624154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.